Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting

SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that four studies on Vectra® will be featured at the...
September 26, 2018 12:41 ET | Source: Myriad Genetics, Inc.

Myriad Announces New GeneSight® Study Published in Personalized Medicine

SALT LAKE CITY, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a worldwide leader in personalized medicine, today announced that a health economic study to evaluate the...
September 25, 2018 11:29 ET | Source: Myriad Genetics, Inc.

Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association

SALT LAKE CITY, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a worldwide leader in personalized medicine, today announced that results from a landmark study of variant...
August 31, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference

SALT LAKE CITY, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president...
August 21, 2018 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results

Total Fourth-Quarter Revenues of $200.9 MillionFourth-Quarter Diluted EPS of $0.18 and Adjusted EPS of $0.38, Up 31 Percent SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc....
August 13, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Reschedules Release of Fiscal Fourth-Quarter 2018 Financial Results

SALT LAKE CITY, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it is moving its fiscal...
August 01, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad to Announce Fiscal Fourth-Quarter 2018 Financial Results on August 14, 2018

SALT LAKE CITY, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal...
July 31, 2018 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Announces Closing of Counsyl Acquisition

SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, announced today that it has completed the acquisition of Counsyl,...
July 25, 2018 16:52 ET | Source: Myriad Genetics, Inc.

Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research

SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced that results from the Individualized Medicine:...
July 18, 2018 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Announces Coverage Decision by Kroger® Prescription Plans for Vectra DA®

SALT LAKE CITY, July 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced that Kroger Prescription Plans, will provide...